English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

and the fourth most common cause of death from cancer worldwide. The current guidelines recommend that screening of individuals at an average risk for CRC be started at the age of 50 years; as a result, the incidence and mortality rate of CRC have decreased in adults above the age of 50 years over the past few decades. In contrast, the incidence in adults aged below 50 years has increased. Bailey et al. demonstrated that the annual incidence of metastatic CRC as well as that of localized CRC has increased in young adults. They predicted that by 2030, the incidence of CRC would increase by 27.7% to 46.0% in individuals aged 35 to 49 years. Korean population-based data also show that the incidence of CRC increased by 78%, 63%, 53%, and 50% in individuals aged 30−34, 35−39, 40−44, and 45−49 years, respectively, between 1999 and 2013. Further, younger patients with CRC have been reported to tend to have more aggressive disease than that observed in older patients, with worse outcomes. A study by Riaz et al. also showed that the majority of patients with young-onset CRC had advanced stage of the disease. Considering that adults aged below 50 years comprise the bulk of the economically active population, an increase in CRC in this demographic may confer a socioeconomic burden in the future. Therefore, clinicians should be concerned about young-onset advanced colorectal neoplasia (ACRN), including CRC. I carefully read the study by Riaz et al. (Red flag symptoms: detailed account of clinicopathological features in young-onset colorectal cancer. Intest Res 2017;15:203-207). The study investigated the clinicopathological features of young-onset CRC (patients aged below 50 years) in Pakistan. Unlike previous studies, in this study, the authors found that the majority of patients with young-onset CRC had no family history of CRC. In young patients, a family history of CRC may be less accurate, because their parents may have not lived long enough to realize their potential of CRC. This may be one of the reasons why a family history of CRC was not associated with young-onset CRC in their study. The study by Riaz et al. showed that most patients with young-onset CRC had a left-sided tumor, and most patients with a left-sided tumor developed rectal bleeding. The authors suggested that painless rectal bleeding in young individuals should alert physicians for appropriate investigation, as the majority of patients with young-onset CRC develop painless bleeding 2 to 3 years before the appearance of other symptoms. However, in the study by Riaz et al., only a small proportion of patients with young-onset CRC were at TNM stage 1 (7.6%) and 2 (16.2%), whereas most of the patients were at stage 4 (40.0%), followed by stage 3 (36.2%). Given that the majority of patients with young-onset CRC were at an advanced stage of the disease, it may be too late to perform endoscopy after the occurrence of symptoms of rectal bleeding. Hence, it is necessary to find young individuals who are expected to have a high risk of CRC. As part of these efforts, several recent studies have examined the risk factors for ACRN in young individuals aged be-

Is colorectal cancer screening necessary before 50 years of age?